Cargando…

In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin

BACKGROUND: Community-acquired urinary tract infections are associated with significant morbidity, and uropathogenic Escherichia coli (UPEC) alone causes 90% of urinary tract infections. This bacterium retains a diverse armament of virulence factors including fimbria, hemolysins, and siderophores pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafaque, Zara, Abid, Nasira, Liaqat, Nida, Afridi, Pashmina, Siddique, Saima, Masood, Safia, Kanwal, Sehrish, Dasti, Javid Iqbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429215/
https://www.ncbi.nlm.nih.gov/pubmed/32848429
http://dx.doi.org/10.2147/IDR.S258355
_version_ 1783571243738333184
author Rafaque, Zara
Abid, Nasira
Liaqat, Nida
Afridi, Pashmina
Siddique, Saima
Masood, Safia
Kanwal, Sehrish
Dasti, Javid Iqbal
author_facet Rafaque, Zara
Abid, Nasira
Liaqat, Nida
Afridi, Pashmina
Siddique, Saima
Masood, Safia
Kanwal, Sehrish
Dasti, Javid Iqbal
author_sort Rafaque, Zara
collection PubMed
description BACKGROUND: Community-acquired urinary tract infections are associated with significant morbidity, and uropathogenic Escherichia coli (UPEC) alone causes 90% of urinary tract infections. This bacterium retains a diverse armament of virulence factors including fimbria, hemolysins, and siderophores production. In a post invasion scenario, formation of intracellular communities mimic biofilm-like characteristics and are linked to recurrent urinary tract infections. We investigated the effects of different frontline antibiotics on the formation, inhibition, and eradication of biofilms of virulent UPEC strains. MATERIALS AND METHODS: A total of 155 UPEC strains were scrutinized for various virulence factors including gelatinase, cell surface hydrophobicity, hemagglutination, and serum bactericidal activity. Biofilm formation was confirmed by three different methods: Congo red agar, test tube, and tissue culture plate method. Biofilm inhibition and eradication assays were performed according to the standard protocols. Topographical analysis of biofilms was done by scanning electronic microscopy (SEM). RESULTS: Out of 155 strains, 113 (73%) were strong biofilm formesr, while 37 (24%) produced biofilms at moderate level. Significant differences were observed between MICs of planktonic cells (MIC-p) and MICs of UPEC biofilms (MIC-b). Among tested frontline antibiotics, levofloxacin successfully inhibited biofilms at a concentration of 32 µg/mL, while trimethoprim eradicated biofilms at higher concentrations (512–1024 µg/mL). Ciprofloxacin treatment at sub-MIC level significantly enhanced biofilm formation (P<0.05). CONCLUSION: The majority of UPEC strains are strong biofilm formers and show higher tolerance towards frontline antibiotics in biofilm form. We observed significant inhibitory effects of levofloxacin (32 µg/mL) on UPEC biofilms, while treatment with sub-minimal concentrations of ciprofloxacin significantly enhanced biofilm formation. Out of all tested antibiotics, trimethoprim (512–1024 µg/mL) eradicated UPEC biofilms.
format Online
Article
Text
id pubmed-7429215
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74292152020-08-25 In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin Rafaque, Zara Abid, Nasira Liaqat, Nida Afridi, Pashmina Siddique, Saima Masood, Safia Kanwal, Sehrish Dasti, Javid Iqbal Infect Drug Resist Original Research BACKGROUND: Community-acquired urinary tract infections are associated with significant morbidity, and uropathogenic Escherichia coli (UPEC) alone causes 90% of urinary tract infections. This bacterium retains a diverse armament of virulence factors including fimbria, hemolysins, and siderophores production. In a post invasion scenario, formation of intracellular communities mimic biofilm-like characteristics and are linked to recurrent urinary tract infections. We investigated the effects of different frontline antibiotics on the formation, inhibition, and eradication of biofilms of virulent UPEC strains. MATERIALS AND METHODS: A total of 155 UPEC strains were scrutinized for various virulence factors including gelatinase, cell surface hydrophobicity, hemagglutination, and serum bactericidal activity. Biofilm formation was confirmed by three different methods: Congo red agar, test tube, and tissue culture plate method. Biofilm inhibition and eradication assays were performed according to the standard protocols. Topographical analysis of biofilms was done by scanning electronic microscopy (SEM). RESULTS: Out of 155 strains, 113 (73%) were strong biofilm formesr, while 37 (24%) produced biofilms at moderate level. Significant differences were observed between MICs of planktonic cells (MIC-p) and MICs of UPEC biofilms (MIC-b). Among tested frontline antibiotics, levofloxacin successfully inhibited biofilms at a concentration of 32 µg/mL, while trimethoprim eradicated biofilms at higher concentrations (512–1024 µg/mL). Ciprofloxacin treatment at sub-MIC level significantly enhanced biofilm formation (P<0.05). CONCLUSION: The majority of UPEC strains are strong biofilm formers and show higher tolerance towards frontline antibiotics in biofilm form. We observed significant inhibitory effects of levofloxacin (32 µg/mL) on UPEC biofilms, while treatment with sub-minimal concentrations of ciprofloxacin significantly enhanced biofilm formation. Out of all tested antibiotics, trimethoprim (512–1024 µg/mL) eradicated UPEC biofilms. Dove 2020-08-12 /pmc/articles/PMC7429215/ /pubmed/32848429 http://dx.doi.org/10.2147/IDR.S258355 Text en © 2020 Rafaque et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Rafaque, Zara
Abid, Nasira
Liaqat, Nida
Afridi, Pashmina
Siddique, Saima
Masood, Safia
Kanwal, Sehrish
Dasti, Javid Iqbal
In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title_full In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title_fullStr In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title_full_unstemmed In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title_short In-vitro Investigation of Antibiotics Efficacy Against Uropathogenic Escherichia coli Biofilms and Antibiotic Induced Biofilm Formation at Sub-Minimum Inhibitory Concentration of Ciprofloxacin
title_sort in-vitro investigation of antibiotics efficacy against uropathogenic escherichia coli biofilms and antibiotic induced biofilm formation at sub-minimum inhibitory concentration of ciprofloxacin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429215/
https://www.ncbi.nlm.nih.gov/pubmed/32848429
http://dx.doi.org/10.2147/IDR.S258355
work_keys_str_mv AT rafaquezara invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT abidnasira invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT liaqatnida invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT afridipashmina invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT siddiquesaima invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT masoodsafia invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT kanwalsehrish invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin
AT dastijavidiqbal invitroinvestigationofantibioticsefficacyagainsturopathogenicescherichiacolibiofilmsandantibioticinducedbiofilmformationatsubminimuminhibitoryconcentrationofciprofloxacin